Sturza's Medical Investment New York City, NY - 10019

Sturza's Medical Investment is categorized under Periodicals, Publishing Only in New York City, NY and active since 1991.

Sturza's Medical Investment was established in 1991, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Periodicals, Publishing Only business, which does work in the B2B market, and is classified as a Periodicals, Publishing Only, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Evan Sturza, Owner at the company’s single location by writing to 1370 Avenue Of The Americas, New York City, New York NY 10019 or by phoning (212) 541-8200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Sturza's Medical Investment
Contact Person: Evan Sturza, Owner
Address: 1370 Avenue Of The Americas, New York City, New York 10019
Phone Number: (212) 541-8200
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1991
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Periodicals, Publishing Only
SIC Code: 2721
NAICS Code: 6214930
Share This Business:

Sturza's Medical Investment was started in 1991 to provide professional Periodicals, Publishing Only under the SIC code 2721 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Evan Sturza, Owner for inquiries that concern Sturza's Medical Investment by calling the company number (212) 541-8200, as your correspondence is most welcome. Additionally, the physical location of the single location of Sturza's Medical Investment can be found at the coordinates 40.76333,-73.97785 as well as the street address 1370 Avenue Of The Americas in New York City, New York 10019.

For its online presence, you may visit Sturza's Medical Investment’s website at and engage with its social media outlets through on Twitter and on Facebook.